Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Medicina (Kaunas) ; 58(10)2022 Sep 27.
Article in English | MEDLINE | ID: mdl-36295518

ABSTRACT

Ever since it was first described in 1760, acute type A aortic dissection has created difficulties in its management. The recent COVID-19 pandemic revealed that extrapulmonary manifestations of this condition may occur, and recent reports suggested that aortic dissection may be amongst them since it shares a common physiopathology, that is, hyper-inflammatory syndrome. Cardiac surgery with cardiopulmonary bypass in the setting of COVID-19-positive patients carries a high risk of postoperative respiratory failure. While the vast majority accept that management of type A aortic dissection requires urgent surgery and central aortic therapy, there are some reports that advocate for delaying surgery. In this situation, the risk of aortic rupture must be balanced with the possible benefits of delaying urgent surgery. We present a case of acute type A dissection with COVID-19-associated bronchopneumonia successfully managed after delaying surgery for 6 days.


Subject(s)
Aortic Dissection , Aortic Rupture , Bronchopneumonia , COVID-19 , Humans , COVID-19/complications , Bronchopneumonia/complications , Pandemics , Aortic Dissection/complications , Aortic Dissection/surgery , Aortic Rupture/complications , Acute Disease , Treatment Outcome
2.
Interact Cardiovasc Thorac Surg ; 9(1): 89-93, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19372098

ABSTRACT

In this study, we tried to compare the efficacy and safety of betaxolol vs. metoprolol immediately postoperatively in coronary artery bypass grafting (CABG) patients and to determine whether prophylaxy for atrial fibrillation (AF) with betaxolol could reduce hospitalization and economic costs after cardiac surgery. Our trial was open-label, randomized, multicentric enrolling 1352 coronary surgery patients randomized to receive betaxolol or metoprolol. The primary endpoints were the composites of 30-day mortality, in-hospital AF (safety endpoints), duration of hospitalization and immobilization, quality of life, and the above endpoint plus in-hospital embolic event, bradycardia, gastrointestinal symptoms, sleep disturbances, cold extremities (efficacy plus safety endpoint). At the end of the study the incidence and probability of early postoperative AF with betaxolol was lower than with metoprolol in coronary surgery (P<0.0001). In the two study groups minor side effects were similar and no major complication was reported (P<0.001). Patient compliance was good and the general condition improved due to shortened hospitalization and immobilization with subsequent improvement in the psychological status, less arrhythmias and lack of significant side effects. In conclusion, because of its efficacy and safety, betaxolol was superior to metoprolol for the prevention of the early postoperative AF in coronary surgery.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Atrial Fibrillation/prevention & control , Betaxolol/therapeutic use , Coronary Artery Bypass/adverse effects , Metoprolol/therapeutic use , Adrenergic beta-Antagonists/adverse effects , Adrenergic beta-Antagonists/economics , Aged , Atrial Fibrillation/economics , Atrial Fibrillation/etiology , Atrial Fibrillation/mortality , Betaxolol/adverse effects , Betaxolol/economics , Cardiopulmonary Bypass , Coronary Artery Bypass/economics , Coronary Artery Bypass/mortality , Cost-Benefit Analysis , Drug Costs , Female , Hospital Costs , Hospital Mortality , Humans , Immobilization , Length of Stay , Male , Metoprolol/adverse effects , Metoprolol/economics , Middle Aged , Patient Compliance , Perioperative Care , Quality of Life , Romania , Time Factors , Treatment Outcome
3.
Kardiol Pol ; 60(6): 535-40, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15334153

ABSTRACT

BACKGROUND: Systemic embolisation occurs in 22% to 50% of patients with infective endocarditis (IE). Up to 65% of embolic events (EE) involve the central nervous system which increases the mortality rate. Several echocardiographic studies have demonstrated higher embolic rates with the increase of vegetation (VEG) dimensions and mobility. AIM: To define echocardiographic parameters which can help in identifying patients with a high risk of EE and to assess the value of transesophageal echocardiography (TEE) in predicting EE in patients with IE. METHODS: 236 patients (58% male, mean age 47.8+/-6) diagnosed with IE according to Duke criteria were followed for 3 years or until cardiac surgery. Echocardiographic parameters measured on VEG included the maximum length, thickness, the narrowest diameter, neck and mobility. RESULTS: The rate of EE was 51.27% without any significant differences with respect to gender, age, fever, anaemia, VEG site or the presence of a significant regurgitation murmur. The univariate analysis showed a significant correlation between EE and IE caused by staphylococcus, IE of the right heart, and the length as well as mobility of VEG. The only independent predictors of EE were the maximum VEG length >15 mm and the increased mobility of VEG with a maximal displacement angle >60.7 degrees. In 23% of patients EE occurred after the initiation of antibiotic treatment. VEG in this group were big and very mobile (length >15 mm, maximal angle of displacement >65 degrees). CONCLUSIONS: 1. Vegetation dimension and mobility determined by TEE are important predictors of the embolic risk. 2. Significant echocardiographic predictors of embolic events included vegetation length >15 mm, neck/thickness ratio >0.69, and maximal angle of displacement of vegetation during cardiac cycle >60.7 degrees. 3. During antibiotic treatment, the embolic risk depends only on vegetation mobility and dimension.


Subject(s)
Echocardiography, Transesophageal , Embolism/etiology , Endocarditis, Bacterial/diagnostic imaging , Adult , Aortic Valve/diagnostic imaging , Embolism/diagnostic imaging , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mitral Valve/diagnostic imaging , Predictive Value of Tests , Risk Factors , Staphylococcal Infections/complications , Staphylococcal Infections/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...